Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: A retrospective study

Inflammation

Volumn 37, Issue 2, 2014, Pages 374-380

  Günay, Ersin ^a   Sarınç Ulaşlı, Sevinç ^a   Akar, Olcay ^a   Ahsen, Ahmet ^a   Günay, Sibel ^b   Koyuncu, Tülay ^a   Ünlü, Mehmet ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b Department Afyon Kocatepe   (Turkey)

Author keywords

C reactive protein; chronic obstructive pulmonary disease; inflammation; mean platelet volume; neutrophil lymphocyte ratio; red cell distribution width

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; ERYTHROCYTE PARAMETERS; FEMALE; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEUTROPHIL TO LYMPHOCYTE RATIO; PROTEIN BLOOD LEVEL; RED CELL DISTRIBUTION WIDTH; RETROSPECTIVE STUDY; THROMBOCYTE VOLUME;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ERYTHROCYTE INDICES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES;

EID: 84896338292     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9749-1     Document Type: Article

References (31)

1. MacNee, W. 2012. Chronic obstructive pulmonary disease: Epidemiology, pathophysiology, and clinical evaluation. In Clinical respiratory medicine, 4th ed, ed. S.G. Spiro, G.A. Silvestri, and A. Agusti, 531-561. Philadelphia: Elsevier Saunders.
2. Hogg, J.C.; F. Chu, S. Utokaparch, R. Woods, W.M. Elliott, L. Buzatu, et al. 2004. The nature of small airway obstruction in chronic obstructive pulmonary disease. New England Journal of Medicine 350: 2645-2653.
3. Eagan, T.M.; J.K. Damås, T. Ueland, M. Voll-Aanerud, T.E. Mollnes, J.A. Hardie, et al. 2010. Neutrophil gelatinase-associated lipocalin: A biomarker in COPD. Chest 138: 888-895.
4. Agustí, A.G.; A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets. 2003. Systemic effects of chronic obstructive pulmonary disease. European Respiratory Journal 21: 347-360.
5. Gan, W.Q.; S.F. Man, A. Senthilselvan, and D.D. Sin. 2004. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax 59: 574-580.
6. Thomsen, M.; T.S. Ingebrigtsen, J.L. Marott, M. Dahl, P. Lange, J. Vestbo, et al. 2013. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 309: 2353-2361.
7. Pinto-Plata, V.M.; H. Müllerova, J.F. Toso, M. Feudjo-Tepie, J.B. Soriano, R.S. Vessey, et al. 2006. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 61: 23-28.
8. Antonescu-Turcu, A.L.; and R. Tomic. 2009. C-reactive protein and copeptin: Prognostic predictors in chronic obstructive pulmonary disease exacerbations. Current Opinion in Pulmonary Medicine 15: 120-125.
9. Hotchkiss, R.S.; and I.E. Karl. 2003. The pathophysiology and treatment of sepsis. New England Journal of Medicine 348: 138-150.
10. Ahsen, A.; M.S. Ulu, S. Yuksel, K. Demir, M. Uysal, M. Erdogan, et al. 2013. As a new inflammatory marker for familial Mediterranean fever: Neutrophil-to-lymphocyte ratio. Inflammation [Epub ahead of print].
11. Núñez, J.; E. Núñez, V. Bodí, J. Sanchis, G. Miñana, L. Mainar, et al. 2008. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. American Journal of Cardiology 101: 747-752.
12. Turkmen, K.; F.M. Erdur, F. Ozcicek, A. Ozcicek, E.M. Akbas, A. Ozbicer, et al. 2013. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodialysis International 17: 391-396.
13. Ertaş, G.; O. Sönmez, M. Turfan, S. Kul, E. Erdoǧan, A. Tasal, et al. 2013. Neutrophil/lymphocyte ratio is associated with thromboembolic stroke in patients with non-valvular atrial fibrillation. Journal of the Neurological Sciences 324: 49-52.
14. Celli, B.R.; W. MacNee, and ATS/ERS Task Force. 2004. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. European Respiratory Journal 23: 932-946.
15. Anthonisen, N.R.; J. Manfreda, C.P. Warren, E.S. Hershfield, G.K. Harding, and N.A. Nelson. 1987. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Annals of Internal Medicine 106: 196-204.
16. Günay, E.; S.S. Ulasli, E. Kacar, B. Halici, E. Unlu, K. Tünay, et al. 2013. Can platelet indices predict obstruction level of pulmonary vascular bed in patients with acute pulmonary embolism? Clinical Respiratory Journal [Epub ahead of print].
17. The Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2013. (Internet) Available from: http://www.goldcopd. org/uploads/users/files/GOLD-Report-2013-Feb20.pdf (Cited 2013 July 31).
18. Stockley, R.A. 2009. Progression of chronic obstructive pulmonary disease: Impact of inflammation, comorbidities and therapeutic intervention. Current Medical Research and Opinion 25: 1235-1245.
19. Schols, A.M.; W.A. Buurman, A.J. Staal van den Brekel, M.A. Dentener, and E.F. Wouters. 1996. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 51: 819-824.
20. Nural, S.; E. Günay, B. Halici, S. Celik, and M. Ünlü. 2013. Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 36: 66-74.
21. Donaldson, G.C.; T.A. Seemungal, I.S. Patel, A. Bhowmik, T.M. Wilkinson, J.R. Hurst, et al. 2005. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 128: 1995-2004.
22. Ulasli, S.S.; B.A. Ozyurek, E.B. Yilmaz, and G. Ulubay. 2012. Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease. Polskie Archiwum Medycyny Wewnȩtrznej 122: 284-290.
23. Wang, R.T.; J.Y. Li, Z.G. Cao, and Y. Li. 2013. The Mean Platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease. Respirology [Epub ahead of print].
24. Steiropoulos, P.; N. Papanas, E. Nena, M. Xanthoudaki, T. Goula, M. Froudarakis, et al. 2012. Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: The role of comorbidities. Angiology [Epub ahead of print].
25. Güngör, B.; K.S. Ozcan, I. Erdinler, A. Ekmekçi, A.T. Alper, D. Osmonov, et al. 2013. Elevated levels of RDW is associated with non-valvular atrial fibrillation. Journal of Thrombosis and Thrombolysis [Epub ahead of print].
26. Ozsu, S.; Y. Abul, S. Gunaydin, A. Orem, and T. Ozlu. 2012. Prognostic value of red cell distribution width in patients with pulmonary embolism. Clinical and Applied Thrombosis/Hemostasis [Epub ahead of print].
27. Ozsu, S.; Y. Abul, A. Gulsoy, Y. Bulbul, S. Yaman, and T. Ozlu. 2012. Red cell distribution width in patients with obstructive sleep apnea syndrome. Lung 190: 319-326.
28. Seyhan, E.C.; M.A. Ozgül, N. Tutar, I. Omür, A. Uysal, and S. AltIn. 2013. Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease. COPD 10: 416-424.
29. Sincer, I.; A. Zorlu, M.B. Yilmaz, O.T. Dogan, M.R. Ege, G. Amioglu, et al. 2012. Relationship between red cell distribution width and right ventricular dysfunction in patients with chronic obstructive pulmonary disease. Heart and Lung 41: 238-243.
30. Celikbilek, M.; S. Dogan, O. OzbakIr, G. ZararsIz, H. Kücük, S. Gürsoy, et al. 2013. Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis. Journal of Clinical Laboratory Analysis 27: 72-76.
31. Okyay, G.U.; S. Inal, K. Oneç, R.E. Er, O. Paşaoǧlu, H. Paşaoǧlu, et al. 2013. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Renal Failure 35: 29-36.